GENI: Form 144 shows planned sale of 202,876 common shares

Rhea-AI Filing Summary

A holder of GENI common stock filed a notice to sell shares under Rule 144. The filing covers 202,876 common shares, to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $2,253,729.20. These shares relate to a recent restricted stock vesting on 01/02/2026, received from the issuer as compensation on that date.

The notice identifies the intended trading market as the NYSE, with an approximate sale date of 01/05/2026. It also discloses that the same seller previously sold 400,673 common shares on 11/10/2025, generating $4,167,039.27 in gross proceeds. The filing reports that 214,097,454 common shares were outstanding for the issuer at the time referenced.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	202876	2253729.20	214097454	01/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2026	Restricted Stock Vesting	Issuer			202876	01/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jack Davison 1st Floor 27 Soho Square London X0 W1D 3QR	Common	11/10/2025	400673	4167039.27

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many GENI shares are planned to be sold under this Form 144?

The notice covers the planned sale of 202,876 shares of GENI common stock, to be sold through Fidelity Brokerage Services LLC.

What is the aggregate market value of the GENI shares to be sold?

The planned sale of 202,876 common shares has an aggregate market value of $2,253,729.20 as stated in the filing.

When are the GENI shares expected to be sold and on which exchange?

The approximate date of sale listed is 01/05/2026, and the filing identifies the NYSE as the securities exchange for the GENI common shares.

How were the GENI shares to be sold acquired by the seller?

The 202,876 GENI common shares were acquired on 01/02/2026 through a restricted stock vesting from the issuer, characterized as compensation.

Has this GENI shareholder sold other shares recently?

Yes. The filing reports that Jack Davison sold 400,673 GENI common shares on 11/10/2025, with $4,167,039.27 in gross proceeds.

How many GENI common shares of the issuer are reported as outstanding?

The filing states that there were 214,097,454 common shares of the issuer outstanding at the referenced time.

What representation does the seller make about GENI in this notice?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.